跳至主要内容
临床试验/NCT03023254
NCT03023254已完成不适用

An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy on Chronic Pruritus in Adults With Plaque Psoriasis

Pierre Fabre Dermo Cosmetique29 个研究点 分布在 2 个国家目标入组 44 人开始时间: 2017年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
29
主要终点
Pruritus clinical criterion

研究概览

简要总结

To assess the benefit of the Avène hydrotherapy in subjects with pruritic plaque psoriasis

详细描述

  • To assess the benefit of the Avène hydrotherapy in subjects with pruritic plaque psoriasis in the:

  • Improvement of pruritus

  • Improvement of psoriasis severity

  • Improvement of quality of life

  • Change of pruritus and psoriasis biological markers

  • Intake/application of treatments and skin care products for psoriasis and pruritus management, evaluated during a follow-up period

  • To assess the time to pruritus relapse evaluated in subjects with pruritic plaque psoriasis, during the period following the Avène hydrotherapy (for the hydrotherapy group only)

  • To assess the global efficacy of the Avène hydrotherapy in pruritic plaque psoriasis, according to subjects' and investigators' opinion (for the hydrotherapy group only)

  • To assess the global cutaneous tolerance of the Avène hydrotherapy in subjects with pruritic plaque psoriasis (for the hydrotherapy group only)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject with plaque psoriasis
  • Subject with moderate to very severe chronic pruritus whose NRS score ≥ 4, (on a scale ranged from 0 to 10)
  • Subject with chronic pruritus, i.e. for at least 6 weeks, due to plaque psoriasis

排除标准

  • Subject with erythrodermic psoriasis, pustular psoriasis or palmoplantar keratoderma
  • Subject with any other type of pruritus, not related to plaque psoriasis
  • Subject with an acute, chronic or progressive disease other than plaque psoriasis which could be the origin of the pruritus
  • Biotherapy, Phototherapy or PUVAtherapy treatment
  • Psoriasis treatment by LASER
  • Systemic or topical treatment taken/applied for psoriasis or pruritus management established or modified since the selection visit or planned to be established or modified between the inclusion visit and the end of the hydrotherapy

结局指标

主要结局

Pruritus clinical criterion

时间窗: Day18

Pruritus intensity assessed by the subject on the NRS from 0 to 10

次要结局

  • Pruritus clinical criterion(Day202)
  • Quality of life criterion(Day1, Day18, Day111 and Day202)
  • Psoriasis clinical criterion(Day1, Day18, Day111 and Day202)
  • Biological criterion (markers linked to neurogenic inflammation, epidermal differentiation, inflammation, antimicrobial peptides)(Day1, Day18, Day111 and Day202)
  • Hydrotherapy criterion(Day18)

研究者

发起方
Pierre Fabre Dermo Cosmetique
申办方类型
Industry
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验